CRP and inflammatory bowel disease: There are some authors that affirmed that weight gain is not associated with IFX treatment in IBD patients [35], while other authors [36] observed only weight gain in a group of patients treated with IFX associated with clinical parameters such as male gender, high CRP, and low levels of albumin.